Hernandez-Anzaldo, Samuel <br/><br/>
Identification of a Novel Heart-Liver Axis: Matrix Metalloproteinase-2 Negatively Regulates Cardiac Secreted Phospholipase A2 to Modulate Lipid Metabolism and Inflammation in the Liver.  [electronic resource] 

 -  Journal of the American Heart Association  Nov 2015 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2047-9980 
<br/><br/><label>Standard No.: </label>10.1161/JAHA.115.002553  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--pharmacology<br/>Animals<br/>Antibodies--pharmacology<br/>Cells, Cultured<br/>Chemokine CCL7--antagonists & inhibitors<br/>Cholesterol, Dietary--metabolism<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation<br/>Genetic Predisposition to Disease<br/>Hepatitis--enzymology<br/>Indoles--pharmacology<br/>Keto Acids<br/>Lipid Metabolism--drug effects<br/>Liver--drug effects<br/>Matrix Metalloproteinase 2--deficiency<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Myocytes, Cardiac--drug effects<br/>Phenotype<br/>Phospholipases A2, Secretory--antagonists & inhibitors<br/>Signal Transduction<br/>Time Factors<br/>Transcription, Genetic<br/>Triglycerides--metabolism